We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$127B
1-Year Est. Return
46.06%
This Fund
S&P 500
This Quarter
Est. Return
+26.15%
1 Year Est. Return
+46.06%
3 Year Est. Return
+142.12%
5 Year Est. Return
+190.33%
10 Year Est. Return
+787.47%
AUM
$127B
AUM Growth
+$26.3B
(+26%)
Cap. Flow
+$9.28B
Cap. Flow
% of AUM
7.32%
Top 10 Holdings %
Top 10 Hldgs %
37.66%
Holding
3,898
New
771
Increased
1,083
Reduced
1,182
Closed
795
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.86B |
| 2 |
Costco
COST
|
+$907M |
| 3 |
AbbVie
ABBV
|
+$643M |
| 4 |
JPMorgan Chase
JPM
|
+$609M |
| 5 |
Bank of America
BAC
|
+$567M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.03B |
| 2 |
Mercado Libre
MELI
|
+$528M |
| 3 |
Broadcom
AVGO
|
+$514M |
| 4 |
SNDK
Sandisk
SNDK
|
+$507M |
| 5 |
Marvell Technology
MRVL
|
+$499M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.91% |
| 2 | Technology | 20.64% |
| 3 | Consumer Discretionary | 9.1% |
| 4 | Healthcare | 8.21% |
| 5 | Financials | 7.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
QuidelOrtho
QDEL
$918M
| $3.02M | ﹤0.01% |
172,500
+40,667
| +31% | +$537K |
|
1602
Cushman & Wakefield Ltd
CWK
$3.11B
| $3.02M | ﹤0.01% |
+225,527
| New | +$3.03M |
|
|
TEN
1603
Tsakos Energy Navigation Ltd
TEN
$1.31B
| $3.02M | ﹤0.01% |
85,368
+14,499
| +20% | +$577K |
|
1604
Ponce Financial Group
PDLB
$492M
| $3.02M | ﹤0.01% |
151,268
-23,124
| -13% | -$423K |
|
1605
Colony Bankcorp
CBAN
$452M
| $3.01M | ﹤0.01% |
150,061
+132,094
| +735% | +$2.67M |
|
1606
Biomea Fusion
BMEA
$140M
| $3.01M | ﹤0.01% |
2,049,802
+851,251
| +71% | +$1.27M |
|
1607
Molina Healthcare
MOH
$10.5B
| $3.01M | ﹤0.01% |
+13,171
| New | +$2.39M |
|
1608
Resideo Technologies
REZI
$2.98B
| $3M | ﹤0.01% |
+96,604
| New | +$3.32M |
|
1609
Packaging Corp of America
PKG
$20.7B
| $2.99M | ﹤0.01% |
12,565
-23,446
| -65% | -$5.14M |
|
|
MPT
1610
Medical Properties Trust
MPT
$2.38B
| $2.99M | ﹤0.01% |
+646,894
| New | +$3.21M |
|
1611
IDEX
IEX
$16.6B
| $2.98M | ﹤0.01% |
13,145
-23,062
| -64% | -$4.88M |
|
1612
Natural Gas Services Group
NGS
$476M
| $2.98M | ﹤0.01% |
69,089
-45,193
| -40% | -$1.84M |
|
|
SORN
1613
Soren Acquisition Corp
SORN
$347M
| $2.98M | ﹤0.01% |
300,000
| – | – |
|
1614
MainStreet Bancshares
MNSB
$182M
| $2.97M | ﹤0.01% |
120,194
+13,969
| +13% | +$329K |
|
1615
AnaptysBio
ANAB
$1.68B
| $2.96M | ﹤0.01% |
43,822
-24,225
| -36% | -$1.47M |
|
1616
Seanergy Maritime Holdings
SHIP
$396M
| $2.95M | ﹤0.01% |
219,950
+45,603
| +26% | +$687K |
|
1617
Gartner
IT
$10.9B
| $2.93M | ﹤0.01% |
22,612
+6,880
| +44% | +$1.04M |
|
1618
Nomura Holdings
NMR
$31.1B
| $2.92M | ﹤0.01% |
+332,986
| New | +$2.77M |
|
|
QXO
1619
QXO Inc
QXO
$13.7B
| $2.92M | ﹤0.01% |
169,144
+52,572
| +45% | +$978K |
|
1620
First American
FAF
$7.29B
| $2.92M | ﹤0.01% |
42,514
+15,314
| +56% | +$1.02M |
|
1621
CALL
Cameco
CCJ
$44.4B
| $2.91M | ﹤0.01% |
28,600
| – | – |
|
1622
Imperial Petroleum
IMPP
$243M
| $2.91M | ﹤0.01% |
630,497
-176,124
| -22% | -$856K |
|
1623
Xylem
XYL
$25.4B
| $2.91M | ﹤0.01% |
24,583
-717,190
| -97% | -$82.8M |
|
1624
Vanguard Health Care ETF
VHT
$19B
| $2.9M | ﹤0.01% |
+9,710
| New | +$2.7M |
|
1625
Southern Company
SO
$102B
| $2.9M | ﹤0.01% |
30,253
-2,303,825
| -99% | -$217M |
|
Similar funds
Marshall Wace's Q2 2026 Portfolio in Review
As of Q2 2026, Marshall Wace held 3,898 positions worth $127B, up 26% from $100B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Marshall Wace deployed $9.28B of net new capital in Q2 2026, opening 771 new positions and adding to 1,083 existing holdings. Its largest new stake was LPL Financial: 975,627 shares worth $275M.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 30% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was NVIDIA, an estimated $1.03B trimmed.
- Marshall Wace's largest Q2 2026 buy was LPL Financial: 975,627 shares worth $275M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.86B increase.
- Marshall Wace's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $1.03B.
- Marshall Wace fully exited Merck in Q2 2026, selling an estimated $325M.
- Marshall Wace's ten largest holdings make up 38% of its $127B portfolio in Q2 2026.
- Marshall Wace opened 771 new positions and closed 795 in Q2 2026.
- Marshall Wace's portfolio value rose 26% quarter-over-quarter to $127B.
Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.